Oprelvekin: A Unique Opportunity to Address Critical Unmet Needs in Cancer Care 2024-12-24
With the development of chemotherapy agents, we've witnessed remarkable strides in the development of chemotherapy agents, resulting in improved efficacy and reduced side effects. However, a critical challenge persists that demands our attention: the management of chemotherapy-induced thrombocytopenia.
Read More